Certain blockbuster weight-loss drugs have been found to protect the heart in significant ways, and new research suggests ...

Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the ...

GLP-1 drugs like Ozempic and Wegovy may help reduce the risk of cardiovascular disease and prevent more than 34,000 heart ...

In early-stage trials, oral weight-loss drugs from Eli Lilly and Novo Nordisk have shown that they can help patients achieve ...

Each year, the Lasker Awards honor a number of medical professionals doing standout work in research and public service. The ...

The increasing popularity of these weight loss drugs is likely to shape how individuals approach food choices and meal ...

Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more ...

The manufacturer of Ozempic is testing amycretin, an experimental weight-loss pill that appears to help people quickly shed ...

Can a popular medication used to change your body also be affecting your mood? It’s a question that some users of semaglutide ...

GLP-1 receptor agonist use was associated with a reduced risk of progressing to cirrhosis and related complications in ...

A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery ...

Businesses can take proactive steps now to best position themselves for a competitive advantage in the face of the seismic shift these medications will have on the industry.